The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis
Open accessAbstract
Familial platelet disorder with predisposition to acute myelogenous leukemia (FPD/AML) is an autosomal dominant familial platelet disorder characterized by thrombocytopenia and a propensity to develop AML. Mutation analyses of RUNX1 in 3 families with FPD/AML showing linkage to chromosome 21q22.1 revealed 3 novel heterozygous point mutations (K83E, R135fsX177 (IVS4 + 3delA), and Y260X). Functional investigations of the 7 FPD/AML RUNX1 Runt domain point mutations described to date (2 frameshift, 2 nonsense, and 3 missense mutations) were performed. Consistent with the position of the mutations in the Runt domain at the RUNX1-DNA interface, DNA binding of all mutant RUNX1 proteins was absent or significantly decreased. In general, missense and nonsense RUNX1 proteins retained the ability to heterodimerize with PEBP2beta/CBFbeta and inhibited transactivation of a reporter gene by wild-type RUNX1. Colocalization of mutant RUNX1 and PEBP2beta/CBFbeta in the cytoplasm was observed. These results suggest that the sequestration of PEBP2beta/CBFbeta by mutant RUNX1 may cause the inhibitory effects. While haploinsufficiency of RUNX1 causes FPD/AML in some families (deletions and frameshifts), mutant RUNX1 proteins (missense and nonsense) may also inhibit wild-type RUNX1, possibly creating a higher propensity to develop leukemia. This is consistent with the hypothesis that a second mutation has to occur, either in RUNX1 or another gene, to cause leukemia among individuals harboring RUNX1 FPD/AML mutations and that the propensity to acquire these additional mutations is determined, at least partially, by the initial RUNX1 mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia
Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H. M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80260-3 · Cited by 1,522
Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
The "megaprimer" method of site-directed mutagenesis.
Sarkar, G., & Sommer, S. S. (1990) · PubMed · Cited by 1,165
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Pabst, T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., & Tenen, D. G. (2001) · Nature Genetics · doi:10.1038/85820 · Cited by 901
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Longley, B. J., Tyrrell, L., Lu, S.-Z., Ma, Y.-S., Langley, K., Ding, T.-G., Duffy, T., Jacobs, P., Tang, L. H., & Modlin, I. (1996) · Nature Genetics · doi:10.1038/ng0396-312 · Cited by 607
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H., et al. (1998) · Nature Genetics · doi:10.1038/1209 · Cited by 586
Lee, B., Thirunavukkarasu, K., Zhou, L., Pastore, L., Baldini, A., Hecht, J., Geoffrey, V., Ducy, P., & Karsenty, G. (1997) · Nature Genetics · doi:10.1038/ng0797-307 · Cited by 567
Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., & Shigesada, K. (1993) · Virology · doi:10.1006/viro.1993.1262 · Cited by 493
Venkatachalam, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4657 · Cited by 449
Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., & Speck, N. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3324-3339.1993 · Cited by 435
Cleidocranial dysplasia: clinical and molecular genetics
Mundlos, S. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.3.177 · Cited by 418
Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., et al. (1999) · Blood · doi:10.1182/blood.v93.6.1817.406k36_1817_1824 · Cited by 397
Zhang, D.-E., Hetherington, C. J., Meyers, S., Rhoades, K. L., Larson, C. J., Chen, H.-M., Hiebert, S. W., & Tenen, D. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1231 · Cited by 396
Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C.-J., van Deursen, J. M. A., Harada, H., & Downing, J. R. (1998) · Blood · doi:10.1182/blood.v91.9.3134 · Cited by 372
The t(8;21) Fusion Protein Interferes with AML-1B-Dependent Transcriptional Activation
Meyers, S., Lenny, N., & Hiebert, S. W. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.4.1974 · Cited by 368
Tahirov, T. H., Inoue-Bungo, T., Morii, H., Fujikawa, A., Sasaki, M., Kimura, K., Shiina, M., Sato, K., Kumasaka, T., Yamamoto, M., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00271-9 · Cited by 327
C-kit mutations in core binding factor leukemias
Beghini, A., Peterlongo, P., Ripamonti, C. B., Larizza, L., Cairoli, R., Morra, E., & Mecucci, C. (2000) · Blood · doi:10.1182/blood.v95.2.726 · Cited by 299
Nuchprayoon, I., Meyers, S., Scott, L. M., Suzow, J., Hiebert, S., & Friedman, A. D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5558 · Cited by 296
Castilla, L. H., Wijmenga, C., Wang, Q., Stacy, T., Speck, N. A., Eckhaus, M., Marín-Padilla, M., Collins, F. S., Wynshaw-Boris, A., & Liu, P. P. (1996) · Cell · doi:10.1016/s0092-8674(00)81388-4 · Cited by 284
Dimerization with PEBP2β protects RUNX1/AML1 from ubiquitin–proteasome‐mediated degradation
Huang, G., Shigesada, K., Ito, K., Wee, H., Yokomizo, T., & Ito, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.4.723 · Cited by 283
Westendorf, J. J., Yamamoto, C. M., Lenny, N., Downing, J. R., Selsted, M. E., & Hiebert, S. W. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.322 · Cited by 270
Preudhomme, C., Warot-Loze, D., Roumier, C., Grardel-Duflos, N., Garand, R., Lai, J. L., Dastugue, N., Macintyre, E., Denis, C., Bauters, F., et al. (2000) · Blood · doi:10.1182/blood.v96.8.2862 · Cited by 263
Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y., & Hirai, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07008.x · Cited by 224
Zhou, G., Chen, Y., Zhou, L., Thirunavukkarasu, K., Hecht, J., Chitayat, D., Gelb, B. D., Pirinen, S., Berry, S. A., Greenberg, C. R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2311 · Cited by 221
Mutation Analysis of Core Binding Factor A1 in Patients with Cleidocranial Dysplasia
Quack, I., Vonderstrass, B., Stock, M., Aylsworth, A., Becker, A., Brueton, L., Lee, P., Majewski, F., Mulliken, J., Suri, M., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302622 · Cited by 212
Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation
Lutterbach, B., & Hiebert, S. W. (2000) · Gene · doi:10.1016/s0378-1119(00)00014-7 · Cited by 209
Zhang, D.-E., Fujioka, K.-I., Hetherington, C. J., Shapiro, L. H., Chen, H.-M., Look, A. T., & Tenen, D. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8085-8095.1994 · Cited by 199
(1995) · PubMed · Cited by 198
Kanno, T., Kanno, Y., Chen, L.-F., Ogawa, E., Kim, W.-Y., & Ito, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2444 · Cited by 192
Self-citationIto, Y. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00298.x · Cited by 179 · cited 1×
“For functional studies of mutated RUNX1 proteins, the wild-type RUNX1 sequence (1-453) was inserted into the pEF-BOS mammalian expression plasmid.”
MethodRequirement of Runx1/AML1/PEBP2αB for the generation of haematopoietic cells from endothelial cells
Yokomizo, T., Ogawa, M., Osato, M., Kanno, T., Yoshida, H., Fujimoto, T., Fraser, S., Nishikawa, S., Okada, H., Satake, M., et al. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00393.x · Cited by 176
Kitabayashi, I., Ida, K., Morohoshi, F., Yokoyama, A., Mitsuhashi, N., Shimizu, K., Nomura, N., Hayashi, Y., & Ohki, M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.846 · Cited by 172
Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Takeuchi, K., Maki, K., Ogawa, S., Chiba, S., Mitani, K., & Hirai, H. (2000) · Blood · doi:10.1182/blood.v96.9.3154 · Cited by 171
Sun, W., Graves, B. J., & Speck, N. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4941-4949.1995 · Cited by 163
Zhang, Y. E., & Derynck, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001526200 · Cited by 144
Molecular Basis of Human Piebaldism
Spritz, R. A. (1994) · Journal of Investigative Dermatology · doi:10.1038/jid.1994.25 · Cited by 143
Accommodating haploinsufficient tumour suppressor genes in Knudson's model
Cook, W. D., & McCaw, B. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203653 · Cited by 127
Warren, A. J., Bravo, J., Williams, R. L., & Rabbitts, T. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.3004 · Cited by 118
Lu, J., Maruyama, M., Satake, M., Bae, S.-C., Ogawa, E., Kagoshima, H., Shigesada, K., & Ito, Y. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1651 · Cited by 110 · cited 1×
“For functional studies of mutated RUNX1 proteins, the wild-type RUNX1 sequence (1-453) was inserted into the pEF-BOS mammalian expression plasmid.”
MethodHo, C. Y., Otterud, B., Legare, R. D., Varvil, T., Saxena, R., Dehart, D. B., Kohler, S., Aster, J. C., Dowton, S. B., Li, F., et al. (1996) · Blood · doi:10.1182/blood.v87.12.5218.bloodjournal87125218 · Cited by 110
Studies of a familial platelet disorder
Dowton, S. B., Beardsley, D. S., Jamison, D., Blattner, S. R., & Li, F. (1985) · Blood · doi:10.1182/blood.v65.3.557.bloodjournal653557 · Cited by 108
Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain.
Werner, M. H., Nagata, T., Gupta, V., Sorce, D., Kim, W., Šali, A., Chait, B. T., Shigesada, K., & Ito, Y. (1999) · Nature Structural Biology · doi:10.1038/10658 · Cited by 101
Meyers, S., Downing, J. R., & Hiebert, S. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6336-6345.1993 · Cited by 94
Kagoshima, H., Akamatsu, Y., Ito, Y., & Shigesada, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.33074 · Cited by 92
Kanno, Y., Kanno, T., Sakakura, C., Bae, S., & Ito, Y. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4252 · Cited by 86
Functional characterization of ETV6 and ETV6/CBFA 2 in the regulation of the MCSFR proximal promoter
Fears, S., Gavin, M., Zhang, D.-E., Hetherington, C., Ben-David, Y., Rowley, J. D., & Nucifora, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1949 · Cited by 78 · cited 1×
“For functional studies of mutated RUNX1 proteins, the wild-type RUNX1 sequence (1-453) was inserted into the pEF-BOS mammalian expression plasmid.”
MethodGerrard, J. M., Israels, E. D., Bishop, A. J., Schroeder, M. L., Beattie, L. L., McNicol, A., Israels, S. J., Walz, D. A., Greenberg, A. H., Ray, M., et al. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb04529.x · Cited by 55
Regulation of GM-CSF gene transcription by core-binding factor.
Cockerill, P. N., Osborne, C. S., Bert, A. G., & Grotto, R. J. (1996) · PubMed · Cited by 51
Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y., Ogawa, S., Mitani, K., Yazaki, Y., & Hirai, H. (1998) · Blood · doi:10.1182/blood.v91.5.1688 · Cited by 48
Horwitz, M. S., Benson, K. F., Li, F.-Q., Wolff, J., Leppert, M., Hobson, L., Mangelsdorf, M., Yu, S., Hewett, D. R., Richards, R. I., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/514894 · Cited by 41
Arepally, G. M., Rebbeck, T. R., Song, W., Gilliland, G. D., Maris, J. M., & Poncz, M. (1998) · Blood · doi:10.1182/blood.v92.7.2600 · Cited by 38
Tanaka, Y., Watanabe, T., Chiba, N., Niki, M., Kuroiwa, Y., Nishihira, T., Satomi, S., Ito, Y., & Satake, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201235 · Cited by 31
Runt domains take the lead in hematopoiesis and osteogenesis
Werner, M. H., Shigesada, K., & Ito, Y. (1999) · Nature Medicine · doi:10.1038/70920 · Cited by 24
Gao, Q. C., Horwitz, M. S., Roulston, D., Hagos, F., Zhao, N., Freireich, E. J., Golomb, H. M., & Olopade, O. I. (2000) · Genes Chromosomes and Cancer · Cited by 20
AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia
Barton, K., & Nucifora, G. (2000) · BioEssays · doi:10.1002/(sici)1521-1878(200003)22:3<214::aid-bies2>3.0.co;2-i · Cited by 20
Austin, G. E., Zhao, W.-G., Regmi, A., Lu, J.-P., & Braun, J. E. (1998) · Leukemia Research · doi:10.1016/s0145-2126(98)00105-2 · Cited by 20
Cited by
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome
Wechsler, J., Greene, M., McDevitt, M. A., Anastasi, J., Karp, J. E., Le Beau, M. M., & Crispino, J. D. (2002) · Nature Genetics · doi:10.1038/ng955 · Cited by 760
Hsu, A. P., Sampaio, E. P., Khan, J., Calvo, K. R., Lemieux, J. E., Patel, S. Y., Frucht, D. M., Vinh, D. C., Auth, R. D., Freeman, A. F., et al. (2011) · Blood · doi:10.1182/blood-2011-05-356352 · Cited by 638
Disruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
Core-binding factors in haematopoiesis and leukaemia
Speck, N. A., & Gilliland, D. G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc840 · Cited by 569
G ENETICS OF M YELOID L EUKEMIAS
Kelly, L. M., & Gilliland, D. G. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.032802.115046 · Cited by 523
Metadata
- Authors
- Michaud, J.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2002-02-15
- Volume
- 99
- Issue
- 4
- Pages
- 1364-1372
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2149787089
- Cited by
- 367
- References
- 61
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.